# UBRELVY
> **NDA211765** · New Drug Application · Sponsor: ABBVIE · Approved 2019-12-23
## Drug
- **FDA Application Number:** NDA211765
- **Application type:** New Drug Application
- **Brand name:** UBRELVY
- **Generic name:** UBROGEPANT
- **Active ingredients:** UBROGEPANT
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ABBVIE
- **Manufacturer:** Allergan, Inc.
- **First approval:** 2019-12-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211765)
---
*MORVS · CC0 1.0*